IPP Bureau
VeerHealth Care announces expansion to enhance healthcare solutions
By IPP Bureau - February 26, 2024
VeerHealth Care will be raising Rs. 8 crores through bank borrowings
Concord Biotech receives GMP certificate from Kenya regulator
By IPP Bureau - February 26, 2024
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
Max Healthcare to acquire land parcel in Lucknow for new hospital
By IPP Bureau - February 26, 2024
The board gave in-principle approval for expansion of company's footprint in Lucknow
Piramal Pharma gets Form 483 with 2 observations from USFDA for Lexington, USA facility
By IPP Bureau - February 26, 2024
The observations do not pose any risk to site's compliance standards or its business continuity
Zydus receives WHO prequalification for Miltefosine formulation and API
By IPP Bureau - February 26, 2024
Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies
Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India
By IPP Bureau - February 24, 2024
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
_Rupak_Singla.jpg "India implementing largest digital programme for TB surveillance")
India implementing largest digital programme for TB surveillance
By IPP Bureau - February 24, 2024
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
Orchid Pharma's 'Exblifep' receives USFDA approval
By IPP Bureau - February 24, 2024
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
.jpg "VP Dhankhar emphasizes need for ethical standards in the medical profession at APICON-2024")
VP Dhankhar emphasizes need for ethical standards in the medical profession at APICON-2024
By IPP Bureau - February 24, 2024
The Vice President also highlighted the importance of preventive healthcare and fitness
AstraZeneca completes acquisition of Gracell
By IPP Bureau - February 23, 2024
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
Aptar Digital Health acquires Healint to broaden neurology portfolio
By IPP Bureau - February 23, 2024
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Jupiter Life Line Hospitals acquires land in Bibvewadi on lease
By IPP Bureau - February 23, 2024
Moderna posts Q4 2023 revenue at US$ 2.8 billion
By IPP Bureau - February 23, 2024
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Ayush and Tribal Affairs Ministries announce joint initiative on public health of tribal students
By IPP Bureau - February 22, 2024
We are achieving the target of developed India by making our young children healthy today
Dr Mandaviya addresses WHO’s public launch event of GIDH
By IPP Bureau - February 22, 2024
Global Initiative on Digital Health (GIDH) was launched by the WHO and the Government of India during the G20 Health Working Group meeting in Gandhinagar last year
